Matterhorn Biosciences
Basel
About Matterhorn Biosciences
Matterhorn is a biotechnology company focusing on the discovery of cellular therapies targeting the MR1 molecule. MR1 presents cancer-specific metabolites on the surface of cancer cells that are recognized and killed by T cells bearing a MR1-specific T cell receptor.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.0M
- Last round: Series Unknown (Aug 2020)
- Website: matterhornbiosciences.com
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/matterhorn-biosciences-118243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.